Pular para o conteúdo principal
Ranking Invest

RDY - Dr. Reddy's Laboratories Limited

Segmento: HealthcareDr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Análise Ranking Invest

Valor de Mercado
$ 11.79 Bi
IVR
41.91Índice proprietário de comparação relativa: 41,91.
IVR2
14.22Leitura proprietária complementar: 1422%.
MLL
14.22Leitura proprietária complementar: 1422%.
Último Balanço Atualizado: 4T2025

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 329.61 Bi

Dívida Líquida

$ 32.11 Bi

L4T

$ 56.54 Bi

MM4T

17.36%

Indicadores Básicos

ROE

17.15%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

B0.19

Margem

A0.12

Índices de Tendência

Receita Líquida

A11.45

Lucro

A8.92

Margem

C3.57

Índices de Endividamento

DIV/PAT

0.10

DIV/L4T

0.57

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.